Home/Filings/4/0001144204-11-023823
4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001144204-11-023823

CIK 0001059784operating

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 4:46 PM ET

Size

5.6 KB

Accession

0001144204-11-023823

Insider Transaction Report

Form 4
Period: 2011-03-25
FLETCHER MARK
EVP & General Counsel
Transactions
  • Award

    Common Stock Purchase Option (right to buy)

    2011-03-25+1,500,0001,500,000 total
    Exercise: $0.28From: 2011-03-25Exp: 2016-03-25Common Stock (1,500,000 underlying)
Footnotes (1)
  • [F1]On March 25, 2011, the Board of Directors of the issuer granted the reporting person options to purchase 1,500,000 shares of the issuer's common stock with an exercise price equal to the closing price of the issuer's common stock on the OTC Bulletin Board on the date of grant. The grant was made pursuant to the terms of the issuer's 2001 and 2006 stock plans. This grant was previously reported on the issuer's Current Report on Form 8-K filed on March 30, 2011.

Documents

1 file

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001059784

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 4:46 PM ET
Size
5.6 KB